This NIH/NIDA grant is offering funding for the development of innovative, cost-effective technologies aimed at reducing disparities in Substance Use Disorders (SUD) treatment. It specifically targets barriers like geographical access, rural/urban divides, high treatment costs, and the pervasive stigma associated with SUDs. The primary goal of this grant is to bring essential treatment directly to patients, eliminating the need for them to travel for care. By supporting field-deployable, low-cost approaches, this grant seeks to significantly enhance the accessibility and availability of SUD diagnosis and treatment, particularly benefiting underserved populations and promoting health equity.
Opportunity ID: 348339
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-24-018 |
| Funding Opportunity Title: | Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 23, 2023 |
| Last Updated Date: | May 23, 2023 |
| Original Closing Date for Applications: | Nov 10, 2023 |
| Current Closing Date for Applications: | Nov 10, 2023 |
| Archive Date: | Dec 16, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $295,924 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See full Notice of Funding Opportunity for additional details on eligibility. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The FOA intends to spur the development of cost-effective technologies that may reduce or even eliminate disparities in SUD treatment. Disparities due to geographical access or rural/urban divide, due to treatment cost, or due to stigma will be specifically targeted. The intention is to bring to the treatment to the patient, not the patient to the treatment. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 348339 Full Announcement-RFA-DA-24-018 -> RFA-DA-24-018-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00281855 | Oct 09, 2023 | Nov 10, 2023 | View |
Package 1
Mandatory forms
348339 RR_SF424_5_0-5.0.pdf
348339 PHS398_CoverPageSupplement_5_0-5.0.pdf
348339 RR_OtherProjectInfo_1_4-1.4.pdf
348339 PerformanceSite_4_0-4.0.pdf
348339 RR_KeyPersonExpanded_4_0-4.0.pdf
348339 RR_Budget_3_0-3.0.pdf
348339 PHS398_ResearchPlan_5_0-5.0.pdf
348339 SBIR_STTR_Information_3_0-3.0.pdf
348339 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
348339 RR_SubawardBudget30_3_0-3.0.pdf
348339 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
